Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06245499 · ClinicalTrials.gov registry record · NA

Aging Brain Care Virtual Program

A NA study of Alzheimer Disease and Dementia, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
989
Enrollment target
1
Study location

NCT06245499 is a NA study of Alzheimer Disease and Dementia that has completed, run by Indiana University. The registered enrollment target is 989 participants, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06245499, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
989 participants
Enrollment target
1
Study location

Study Summary

The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which patient and caregiver needs are identified during visits using validated assessment tools and addressed with standardized protocols. Protocols include management of behavioral/psychological symptoms of dementia, caregiver stress, medication management, comorbidity management and advance care planning.

Interventions

  • BEHAVIORAL Aging Brain Care Virtual Program

Study Locations (1)

Indiana

  • Regenstrief Institute, Inc. - Indianapolis

Trial Details

FieldValue
Enrollment Target 989 participants
Start Date 2024-03-11
Est. Completion 2025-10-31
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06245499

The ClinicalTrials.gov registry entry for NCT06245499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 989 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Aging Brain Care Virtual Program is the first listed.

NCT06245499 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06245499 about?

NCT06245499 is a clinical study titled "Aging Brain Care Virtual Program". The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which pat...

What is the current status of trial NCT06245499?

This trial is currently completed. It is a NA study. The enrollment target is 989 participants. The study started on 2024-03-11. Estimated completion is 2025-10-31.

What conditions does trial NCT06245499 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia.

What interventions are being tested in trial NCT06245499?

The interventions under investigation include: Aging Brain Care Virtual Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06245499?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06245499 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.